GuyattGRennieD.
Users' Guides to the Medical Literature: A Manual for
Evidence-Based Clinical Practice. Chicago,
IL: American Medical
Association; 2002.
2.
GreenhalghTHowickJMaskreyN; Evidence
Based Medicine Renaissance Group. Evidence based
medicine: a movement in crisis?BMJ.2014;348:g3725.
3.
AnselGMJaffMR. The
“art” of medicine and the “smokescreen” of the
randomized trial off-label use of vascular devices.
Catheter Cardiovasc Interv.2008;72:998–1002.
4.
TsilimparisNLohrenzCPflugradtA. Back-table modification of a
bifurcated infrarenal stent-graft to aortomonoiliac for
emergencies. J Endovasc Ther.2014;21:348–352.
5.
Biondi-ZoccaiGGAgostoniPSangiorgiG. Mastering the antegrade femoral
artery access in patients with symptomatic lower limb ischemia: learning
curve, complications, and technical tips and tricks.
Catheter Cardiovasc Interv.2006;68:835–842.
6.
SultanSHynesN.
One-year results of the multilayer flow modulator stent in
the management of thoracoabdominal aortic aneurysms and type B
dissections. J Endovasc Ther.2013;20:366–377.
7.
LichtenbergMKolksOHailerB. PEACE I all-comers registry: patency
evaluation after implantation of the 4-French Pulsar-18 self-expanding
nitinol stent in femoropopliteal lesions. J Endovasc
Ther.2014;21:373–380.
8.
StroblFFBrechtelKSchmehlJ. Twelvemonth results of a randomized
trial comparing mono with dual antiplatelet therapy in endo-vascularly
treated patients with peripheral artery disease. J
Endovasc Ther.2013;20:699–706.
9.
de BruinJLYeungKKNiepothWW. Geometric study of various chimney
graft configurations in an in vitro juxtarenal aneurysm
model. J Endovasc Ther.2013;20:184–190.
10.
WipperSLohrenzCAhlbrechtO. Antegrade side branch access in
branched aortic arch endografts: a porcine feasibility
study. J Endovasc Ther.2013;20:233–241.
11.
BrottTGHobsonRWHowardG.; CREST Investigators.
Stenting versus endarterectomy for treatment of
carotid-artery stenosis. N Engl J Med.2010;363:11–23.
12.
CooperCJMurphyTPCutlipDE.; CORAL Investigators.
Stenting and medical therapy for atherosclerotic renal-artery
stenosis. N Engl J Med.2014;370:13–22.
13.
Biondi-ZoccaiGGSangiorgiGLotrionteM. Infragenicular stent implantation for
below-the-knee atherosclerotic disease: clinical evidence from an
international collaborative meta-analysis on 640 patients.
J Endovasc Ther.2009;16:251–260.
14.
Biondi-ZoccaiGLandoniGModenaMG. A
journey into clinical evidence: from case reports to mixed treatment
comparisons. HSR Proc Intensive Care Cardiovasc
Anesth.2011;3:93–96.
15.
Biondi-ZoccaiG, ed. Network
Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison.Hauppauge, NY: Nova Science
Publishers; 2014.
16.
D'AscenzoFBollatiMClementiF. Incidence and predictors of coronary
stent thrombosis: evidence from an international collaborative meta-analysis
including 30 studies, 221,066 patients, and 4276 thromboses.
Int J Cardiol.2013;167:575–584.
17.
Biondi-ZoccaiGLotrionteMAgostoniP. Adjusted indirect comparison
meta-analysis of prasugrel versus ticagrelor for patients with acute
coronary syndromes. Int J Cardiol.2011;150:325–331.
18.
PalmeriniTBiondi-ZoccaiGDella RivaD. Clinical outcomes with bioabsorbable
polymer-versus durable polymer-based drug-eluting and bare-metal stents:
evidence from a comprehensive network meta-analysis.
J Am Coll Cardiol.2014;63:299–307.
19.
TheodoratouETzoulakiIZgagaL. Vitamin D and multiple health
outcomes: umbrella review of systematic reviews and meta-analyses of
observational studies and randomised trials.
BMJ.2014;348:g2035.
20.
WaldNJMorrisJK.
Teleoanalysis: combining data from different types of
study. BMJ.2003;327:616–618.
21.
LangwieserNBuyerDSchusterT. Bare metal vs. drug-eluting stents
for extracranial vertebral artery disease: a meta-analysis of nonrandomized
comparative studies. J Endovasc Ther.2014;21:683–692.